By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS



The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.



Key Statistics


Email: contactus@themedco.com
Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO
 





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient

Alnylam 





Company News
The Medicines Company (MDCO) And Alnylam (ALNY) Present Positive Results From ORION-1 Phase II Study Of Inclisiran (formerly PCSK9si) 11/15/2016 11:32:05 AM
Alnylam (ALNY) And The Medicines Company (MDCO) Announce Publication Of Phase 1 Clinical Data With Inclisiran (ALN- PCSsc) In The New England Journal of Medicine 11/14/2016 12:24:27 PM
The Medicines Company (MDCO) To Host Conference Call And Webcast To Review Data From Ongoing ORION-1 Phase II Study Of PCSK9si 11/10/2016 2:17:10 PM
The Medicines Company (MDCO) Abandons Development of Plaque Buster MDCO-216; Will Dump Cash Into PCSK9 Instead 11/8/2016 5:27:52 AM
The Medicines Company (MDCO) Reports Third-Quarter 2016 Financial Results 10/26/2016 10:08:03 AM
The Medicines Company (MDCO) Announces Positive Top-Line Results From Day 90 Interim Analysis In Ongoing ORION-1 Phase 2 Study Of PCSK9si 10/18/2016 1:44:21 PM
The Medicines Company (MDCO) To Announce Third Quarter Financial Results On October 26, 2016 10/18/2016 12:02:56 PM
The Medicines Company (MDCO) To Present Data From Its Investigational Anesthetic MDCO-700 At The ANESTHESIOLOGY 2016 Annual Meeting And The ISAP 25th Annual Meeting 10/13/2016 12:31:13 PM
The Medicines Company (MDCO) To Present Data From Its Investigational Anesthetic MDCO-700 At The ANESTHESIOLOGY 2016 Annual Meeting And The ISAP 25th Annual Meeting 10/13/2016 11:58:51 AM
The Medicines Company (MDCO) Provides Progress Update On Ongoing ORION-1 Study Of PCSK9si 10/6/2016 11:41:56 AM
12345678910...
//-->